CICT achieves positive 2H 2024 performance with distributable income up 6.4% year-on-year ...
CICT is in a position of strength after successful portfolio reconstitution, anchored by resilienceSingapore, February 5, ...
Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock
Nuvectis intends to use the net proceeds from the offering to continue to advance the development programs of NXP800 and NXP900 or any future product candidate, hiring of additional personnel, capital ...